Search results
Results From The WOW.Com Content Network
The guidelines recommend BP threshold to initiate pharmacological therapy, BP treatment targets, intervals for follow-up visits, and best use of health care workers in the management of hypertension.
The 2023 European Society of Hypertension (ESH) and 2017 American College of Cardiology/American Heart Association (ACC/AHA) hypertension guidelines both emphasize proper blood pressure (BP) measurement, cardiovascular (CV) risk assessment, optimal lifestyle interventions, and specific pharmacotherapy management.
The AHA/ACC has released a scientific statement in 2021 offering new guidance for management of stage 1 hypertension among patients with low ASCVD risk. Among low-risk adults (no ASCVD or 10-year CVD risk <10%) with stage 1 hypertension (blood pressure 130-139/80-89 mmHg), management starts with nonpharmacologic therapy.
The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure” replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the “2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure.”
The ACC/AHA guideline provides 106 formal recommendations and the ESC/ESH provides 122. In both guidelines, each recommendation is characterized by a class of recommendation that specifies the strength or importance of the recommendation and by a level-of-evidence designation.
Guideline Clinical App gives you access clinical guideline content, guideline recommendations, "10 Points" summaries, and tools such as risk scores and calculators. Tip: After submitting key term, narrow your results by filtering by clinical topic or selecting specific document types.
• The 2017 ACC/AHA guideline lowered the SBP goal of therapy from <140 to <130 mm Hg. This recommendation focused on the cut point at which there is likely to be benefit from antihypertensive drug therapy. • But many individuals classified as low risk based on their ASCVD risk score have subclinical atherosclerosis (based on coronary